One of the current gaps in current #breastcancer research is whether or not to do routine screening for brain metastases in patients with metastatic breast cancer who don’t have any concerning symptoms for brain metastases. Historically, we did not screen for brain metastases because therapies were toxic and we didn’t have good therapies but things are changing w better therapies (although we still have a way to go). This has raised the question of whether we should do brain imaging in people w

Chemotherapy Side Effects

Sylvester Comprehensive Cancer Center

The Cancer Genome Atlas (TCGA)

Lucid Diagnostics annonce que les directives actualisées du National Comprehensive Cancer Network (NCCN) incluent désormais le dépistage des lésions précancéreuses de l'œsophage.